Roivant and Kinevant Sciences have recently announced the successful completion of enrollment in their Phase study assessing namilumabs efficacy in treating chronic pulmonary sarcoidosis
CSL Vifor and Travere Therapeutics Inc jointly announced today that FILSPARI has been granted conditional marketing authorization by the European Commission
Tetra Pharm Technologies and Glysious are excited to announce a new collaboration aiming to revolutionize transdermal drug delivery systems The partnership intends to enhance several of Tetra
Regeneration Biomedical Inc a company focused on developing stem cell therapies for neurodegenerative diseases has reached a significant milestone by dosing the first patient in a Phase
GenScript Biotech Corporation and Multiply Labs have teamed up to transform the cell therapy manufacturing process Their partnership focuses on automating the intricate cell isolation phase
Averoa a biopharmaceutical company focused on innovative therapeutic solutions for renal diseases has announced the submission of a marketing authorization application to the European Medicines
Starton Therapeutics Inc a clinicalstage biotechnology company transforming standardofcare therapies with proprietary dermal technologies announced today the successful completion of enrollment for its STARLLD Phase b clinical trial
Parexel one of the worlds largest clinical research organizations providing the full range of Phase I to IV clinical development services and Palantir Technologies Inc a leading builder of Artificial Intelligence systems today announced a multiyear
Arrowhead Pharmaceuticals Inc announced today that it has dosed the first subjects in a Phase a clinical trial of AROCFB the companys investigational RNA interference therapeutic in up to healthy volunteers and patients with complement
BioAffinity Technologies Inc a biotechnology company focused on the need for noninvasive accurate tests for the detection of earlystage lung cancer and other lung diseases today announced David Elzi PhD has been named Vice President
Boston, MA, USA
Amsterdam, Netherlands
Boston, MA, USA
London, UK
Boston, MA, USA
Boston, MA, USA
Boston, MA, USA
Bangkok, Thailand
Kate, Editorial Team at Pharma Focus Europe, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.
Kate, Editorial Team at Pharma Focus Europe, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.
Kate, Editorial Team at Pharma Focus Europe, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.
Kate, Editorial Team at Pharma Focus Europe, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.
Kate, Editorial Team at Pharma Focus Europe, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.
In the realm of healthcare few advancements hold as much promise and controversy as gene editing and genetic engineering These technologies once confined to science fiction are now tangible tools
In the realm of healthcare where every decision has significant financial implications pharmacoeconomics plays a pivotal role It involves the evaluation of the economic impact of pharmaceutical products and services
In the dynamic field of biological sciences the fusion of bioinformatics and computational biology has catalyzed a paradigm shift in genome analysis This synergistic collaboration harnesses cuttingedge computational tools statistical models
Pharmaceutical viral vectors have emerged as powerful tools in gene therapy vaccine development and biotechnology research The ability of viral vectors to deliver genetic material into target cells
Did you know that smart packaging has the potential to revolutionize the pharmaceutical industry With trackandtrace solutions this innovative technology can enhance transparency safety and efficiency in the pharma supply chain
In todays world where sustainability is a top priority breaking down barriers to a greener future is crucial One area where advancements are being made is in the field of biodegradable drug delivery
The streptothricin natural product mixture also known as nourseothricin was discovered in the early s generating intense initial interest because of excellent gramnegative activity
A microfluidic device has been created by a team of researchers led by the University of California San Diego which measures how sticky cancer cells are and how they could improve prognostic evaluation of patient tumors
Biotechnology an industry at the forefront of scientific innovation and transformative healthcare solutions
Recent industry pressures brought on by the global COVID pandemic provided critical lessons for the life sciences industry
Today there are more than known rare diseases defined by the European Union as conditions that affect less than in people
Continuous manufacturing methods have been extensively demonstrated to have a significant impact on improving quality
In drug discovery AI is being used to predict the efficacy and safety of potential drug candidates identify new therapeutic targets and optimize clinical trial designs
With more clinical trials getting decentralized and the adoption of AIML witnessing an upward trend